Concepedia

Publication | Open Access

Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

424

Citations

20

References

2011

Year

Abstract

In this study, CML-related deaths were uncommon in CML patients who were in CCyR 2 years after starting imatinib, and survival was not statistically significantly different from that of the general population.

References

YearCitations

Page 1